The UK Government has expanded the Global Talent visa route to more than 100 commercial businesses, including AstraZeneca, IBM and Jaguar Land Rover, giving employers with significant R&D functions a new route to recruit overseas researchers outside conventional visa sponsorship, at a time when specialist scientific and engineering talent remains scarce.

The UK Government, through the Department for Business and Trade, announced the change on 6 August 2026. It extends the UKRI Endorsed Funder pathway, previously used mainly by universities and academic institutions, into commercial businesses across quantum, nuclear, biotechnology, advanced manufacturing and renewable energy.

The strategic logic centres on portability. Unlike the Skilled Worker visa, Global Talent status is not tied to a single employer, letting holders change jobs, become self-employed or start a business without fresh immigration permission, a structural advantage for employers competing internationally for scarce specialist talent.

Business secretary Jonathan Reynolds said the government wants to make it easier for the UK's most innovative companies to recruit eligible researchers to develop the medicines, technologies and industries of the future domestically. Yash Dubal, director at A Y & J Solicitors, said the change brings the Global Talent route more firmly into the commercial world, since much of the UK's most innovative research now happens inside businesses rather than academic institutions.

More than 12,500 people from over 130 countries have already entered the UK through the Endorsed Funder pathway, a figure the government expects to grow following the commercial expansion, alongside a separate £54 million Global Talent Fund and dedicated Global Talent Taskforce.

For the sector, the change signals a broader government shift toward flexible, employer-agnostic visa routes as a recruitment lever for R&D-intensive employers, meaning HR and immigration teams should reassess whether Global Talent now offers a more competitive alternative to conventional sponsorship for specialist scientific and engineering hires.

Source: theHRDIRECTOR